Vanguard Group Inc Aura Biosciences, Inc. Transaction History
Vanguard Group Inc
- $5.97 Trillion
- Q2 2025
A detailed history of Vanguard Group Inc transactions in Aura Biosciences, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 2,477,502 shares of AURA stock, worth $14.8 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,477,502
Previous 1,952,333
26.9%
Holding current value
$14.8 Million
Previous $11.4 Million
35.57%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding AURA
# of Institutions
105Shares Held
51.5MCall Options Held
0Put Options Held
0-
Matrix Capital Management Company, LP Waltham, MA6.92MShares$41.3 Million22.54% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA5.1MShares$30.4 Million1.68% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA4.88MShares$29.1 Million0.05% of portfolio
-
Long Focus Capital Management, LLC San Juan, PR4.62MShares$27.6 Million1.33% of portfolio
-
Suvretta Capital Management, LLC New York, NY4.37MShares$26.1 Million0.94% of portfolio
About Aura Biosciences, Inc.
- Ticker AURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,273,600
- Market Cap $175M
- Description
- Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develop...